Evaluation of Exenatide in Patients With Diabetic Neuropathy

Completed · Not applicable

Conditions studied: Type 2 Diabetes Mellitus, Diabetic Peripheral Neuropathy

In brief

This study will look at whether or not the medication exenatide improves signs and symptoms of diabetic peripheral neuropathy in people with type 2 diabetes and mild to moderate diabetic peripheral neuropathy.

Key facts

Study ID
NCT00855439
Run by
University of Michigan
People needed
46
Starts
2008-06-01
Expected to finish
2014-05-01
Last updated by the study team
2017-03-01

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.